1.95000 USD
0.04
2.01%
Last update Dec 17, 3:59 PM EST
Market closed
Day range
1.87000
2.17000
Previous close
1.99000
Open
2.030000
Access this stock data via API
Subscribe
Prelude Therapeutics Incorporated
1.95
0.04
2.01%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 6.5M 0 0 4M
Cost of revenue
Gross profit
Operating expense
Research & development 21.7M 25.8M 28.8M 31.6M
Selling general and admin 5.2M 6.4M 5.8M 6.2M
Other operating expenses
Operating income -20.4M -32.2M -34.6M -33.8M
Non operating interest income
Income
Expense
Other income expense 693K 963K 2.5M 5.1M
Pretax income -19.7M -31.2M -32.1M -28.7M
Tax provision
Net income -19.7M -31.2M -32.1M -28.7M
Basic EPS -0.3 -0.4 -0.4
Diluted EPS -0.3 -0.4 -0.4
Basic average shares 76.1M 76.0M 76.0M
Diluted average shares 76.1M 76.0M 76.0M
EBITDA -20.0M -31.8M -34.2M -33.3M
Net income from continuing op. -19.7M -31.2M -32.1M -28.7M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 2 hours 58 minutes

01:01
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).